Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.
Jan 21, 2025•20 min•Ep. 342
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.
(00:32)
Would you mind telling us a little bit about yourself and your background?
(01:58)
Would you give us an overview of membranous nephropathy?
(07:14)
Could you tell us a little bit about this new assay?
(14:29)
Could you give a little example of how a clinician might use this information to treat their patients differently than how they would've in the past?
For the best experience, listen in Metacast app for iOS or Android